The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome

International Journal of Cardiology
Kyeong Ho YunJin-Won Jeong

Abstract

Statin therapy prior to percutaneous coronary intervention (PCI) is associated with reduced mortality and periprocedural myocardial injury after PCI. We studied whether single high dose statin loading is beneficial on the outcome of patients with acute coronary syndrome (ACS) underwent PCI. Consecutive 445 patients with ACS who underwent PCI were randomly assigned to either the group of no statin treatment before PCI (Control group: n=220, 63+/-11 years, male 62%) or the group of 40 mg rosuvastatin loading before PCI (Rosuvastatin group: n=225, 64+/-10 years, male 60%). Incidence of periprocedural myocardial injury was assessed by analysis of creatinine kinase-MB (CK-MB) and cardiac troponin T before PCI, at 6 h and the next morning after PCI. There were no significant differences in clinical characteristics between the two groups. After PCI, incidence of periprocedural myocardial injury was higher in control than in rosuvastatin group (11.4% versus 5.8%, p=0.035). Mean preprocedural CK-MB and high sensitivity C-reactive protein were similar between the two groups, whereas after PCI, peak values of both markers were elevated significantly higher in control than in rosuvastatin group. Multivariate analysis revealed that no prior...Continue Reading

References

Jun 4, 2002·European Heart Journal·S J BrenerE J Topol
Oct 24, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Victor Sánchez-MargaletRaimundo Goberna
Sep 24, 2005·European Heart Journal·Joerg Herrmann
Nov 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Young Joon HongJung Chaee Kang
Oct 24, 2007·Circulation·Kristian ThygesenNawwar Al-Attar
Dec 3, 2008·International Journal of Cardiology·Andrew J S Coats

❮ Previous
Next ❯

Citations

Oct 12, 2010·Future Cardiology·Annunziata NuscaGermano Di Sciascio
Apr 5, 2011·International Journal of Hypertension·Enrique C Morales-VillegasCarlo Briguori
Feb 6, 2010·Current Medical Research and Opinion·Vasilios G AthyrosDimitri P Mikhailidis
Mar 20, 2013·The American Journal of Cardiology·Hitoshi TakanoUNKNOWN PRIMITIVE Study Investigators
Oct 2, 2013·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Darío Echeverri, Jaime Cabrales
Feb 14, 2012·International Journal of Cardiology·Jan F ScheitzChristian H Nolte
Jan 17, 2012·Journal of the American College of Surgeons·Primal P SinghAndrew G Hill
Nov 26, 2010·International Journal of Cardiology·Kyeong Ho Yun
Mar 2, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Francesca CorteseMarco Matteo Ciccone
Nov 9, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Glenn N LevineUNKNOWN Society for Cardiovascular Angiography and Interventions
Nov 26, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Alexandre M BenjoJacqueline E Tamis-Holland
Apr 12, 2013·Expert Opinion on Pharmacotherapy·Rajesh K Aggarwal, Refai Showkathali
Aug 14, 2012·La Presse médicale·Pierre Ambrosi
Sep 10, 2010·Journal of the American College of Cardiology·David E WinchesterAnthony A Bavry
Sep 10, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Joanne Guay, E Andrew Ochroch
Mar 20, 2010·JACC. Cardiovascular Interventions·Carl J Lavie, Richard V Milani
Jun 24, 2014·American Heart Journal·Mohamad KenaanUNKNOWN Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
Jul 30, 2014·American Heart Journal·Mohamad Kenaan, Hitinder S Gurm
Oct 14, 2014·Journal of Thrombosis and Thrombolysis·Travis R SextonSusan S Smyth
Feb 1, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·Zhengzhong WangZhiming Ge
Aug 9, 2017·Journal of Interventional Cardiology·Konstantinos LampropoulosAntonios Manolis
Sep 2, 2014·The Cochrane Database of Systematic Reviews·Noah ValeMatthias Briel
Nov 4, 2009·Circulation·Gerd HeuschRaimund Erbel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.